Is the lithium battery industry chain about to bottom out? Insiders predict that prices are expected to rebound next year, with industry leaders emphasizing global layout | Exclusive coverage of the High Work Lithium Battery Annual Conference.
① At the 2024 High-tech Lithium Battery Annual Conference held yesterday, Zhang Xiaofei, chairman of High-tech Lithium Battery, predicted that the first quarter of next year will be the lowest price point, and in the second quarter of next year, the prices of battery raw materials will begin to rise; ② The future industry will face a more severe competitive landscape and capacity thresholds, and the solution offered by leading enterprises is to expand overseas.
Capacity going global again with yunnan energy new material planning to invest 2 billion yuan in building a separator project in Malaysia | Quick read announcement
①yunnan energy new material plans to invest 2 billion yuan to build a membrane isolation project in Malaysia, with a planned construction capacity of approximately 1 billion square meters per year; ②since the beginning of this year, the company has continued to increase its overseas production capacity construction plans and announced in June a planned investment of 0.447 billion euros in the second phase of Hungary.
The State Tobacco Monopoly Administration has released new regulations on electronic cigarettes, and there is expected to be further improvement in market share for leading companies.
The State Tobacco Monopoly Administration issued a notice on the revision and implementation of the Regulations on the Management of Electronic Cigarette Transactions. The notice mentions that the competent administrative department of tobacco monopoly of the State Council will establish a nationwide unified electronic cigarette trading management platform. Caitong Securities' Lv Mingzhang pointed out that in the long term, non-compliant products will gradually be cleared, and market share is expected to further concentrate, which is bullish for leading companies in production, brand and other aspects.
Director of Shandong Jincheng Pharmaceutical Group investigated for suspected stock market manipulation. Q1 performance just turned around according to announcement.
On the evening of today, Shandong Jincheng Pharmaceutical Group announced that its actual controller and chairman, Zhao Yeqing, was under investigation for suspected illegal acts of market manipulation by the China Securities Regulatory Commission. Zhao Yeqing has been the chairman of Jincheng Pharmaceutical Group for 13 years. The last time he appeared in public was at the 3rd China Pharmaceutical and Chemical Conference two days ago. In Q1 of 2024, Jincheng Pharmaceutical Group has shown a good trend of reversing last year's poor performance.
December 24 review: With sufficient reserve momentum this week, next week saw a substantial increase in trading volume as block orders targeted 5 stocks.
On December 24th, the three major indices opened higher and then fell back, with the Shanghai Composite Index maintaining a low consolidation, while the ChiNext Price Index led the decline in the two cities. In terms of sectors, the medical sector collectively surged, with traditional Chinese medicine stocks leading the gains, while food processing, retail, and other consumer stocks were active against the trend; new energy sectors such as lithium batteries, photovoltaics, and energy storage all fell across the board, with the heavyweight Contemporary Amperex Technology dropping over 9% intraday. The indices continued to weaken in the afternoon, with the ChiNext Price Index's decline expanding to 2.7% at one point. Stocks related to nurturing diamonds and the non-fungible token (NFT) concept surged, while sectors like autos, rare earths, fluorine chemicals, and digital currency remained sluggish. Overall, market sentiment is cooling, and individual stocks are showing a general downward trend in the two cities
Yunnan Energy New Material’s Profit More Than Doubles in Q3 Even as Revenue Misses Estimates